Short answer
The Bridge runs through 2027, and the path after it is not yet confirmed.
CMS says the Medicare GLP-1 Bridge was extended through December 31, 2027, to collect data ahead of potential implementation of the BALANCE Model in Part D. The Part D piece of BALANCE has been indefinitely delayed, and CMS has not confirmed a guaranteed weight-management coverage path for Medicare beneficiaries after the Bridge ends. For covered medical indications, such as type 2 diabetes, cardiovascular risk reduction, and sleep apnea, Part D coverage continues regardless of the Bridge.
Start here
What you actually came to find out
Plain answers first. Sources stay below for checking details.
When does the Bridge end?
CMS says December 31, 2027, after an extension.
What comes next?
CMS points to potential BALANCE in Part D, which is delayed.
Is coverage guaranteed after?
Not confirmed. CMS has not set a guaranteed path yet.
What still continues?
Part D coverage for diabetes, heart-risk, and sleep apnea continues.
End date
Dec 31, 2027
CMS says the Bridge was extended through the end of 2027.
Source trail: CMS
Next step
BALANCE, delayed
CMS points to potential BALANCE in Part D, which KFF says is indefinitely delayed.
After 2027
Not confirmed
CMS has not confirmed a guaranteed weight-management path after the Bridge.
Source trail: CMS
Medical uses
Continue
Part D coverage for diabetes, heart-risk, and sleep apnea continues regardless.
Source trail: Congressional Research Service
The honest read is two-sided: medical-indication coverage continues, but weight-management access after 2027 is genuinely unsettled, so it is worth watching rather than assuming.
Neutral landscape
The shape of the question
CMS is the main source because it states the Bridge extension through December 31, 2027 and its purpose.
Source trail: CMS
The next step is uncertain, since CMS points to potential BALANCE in Part D while KFF reports that piece is indefinitely delayed.
The honest gap is what follows, because no CMS source confirms a guaranteed weight-management path after 2027.
Source trail: CMS
The stable part is medical-indication coverage, which the CRS shows continues under Part D.
Source trail: Congressional Research Service
Curator core
What the authorities say
These sources are here for the reader who wants to check the work. The plain-English answer stays above them.
Source 01
CMS
Medicare GLP-1 Bridge
CMS explains the Medicare GLP-1 Bridge, a short-term demonstration giving eligible Part D beneficiaries access to certain GLP-1 drugs from July 1, 2026 through December 31, 2027.
Source framing
CMS says the Medicare GLP-1 Bridge is a short-term demonstration running July 1, 2026 through December 31, 2027, using a central processor and a flat monthly copay outside the Part D benefit.
Strongest for: how the new Medicare GLP-1 Bridge works and who is eligible
Read at CMSSource 02
KFF
GLP-1s in Medicare and Medicaid
KFF tracks GLP-1 coverage across Medicare and Medicaid, including how many states cover obesity treatment and how the Part D out-of-pocket cap rises.
Source framing
KFF reports that coverage of GLP-1s for obesity is required for medical indications but optional for weight loss in Medicaid, with only 13 states covering obesity treatment as of January 2026.
Strongest for: the state count for Medicaid obesity coverage and out-of-pocket-cap figures
Read at KFFSource 03
Congressional Research Service
Medicare Coverage of GLP-1 Drugs
The Congressional Research Service summarizes Medicare coverage of GLP-1 drugs, including the statutory weight-loss exclusion and coverage for diabetes and cardiovascular indications.
Source framing
The Congressional Research Service says GLP-1 drugs are not covered under Part D when used for weight loss, but are covered for medically accepted indications such as type 2 diabetes and cardiovascular risk reduction.
Strongest for: the weight-loss exclusion and the covered medical indications
Read at Congressional Research ServicePlain-English forks
The forks people face
Most retirement questions hide a few smaller decisions. These are the practical pieces that change the plan.
Is your use medical or weight management?
Why it matters: Medical-indication coverage continues; weight-management access is the open question.
In real life: This fork tells you whether 2027 affects you.
What to look at: What to look at: the covered indications versus the Bridge.
Are you relying on the Bridge?
Why it matters: The Bridge ends December 31, 2027, with no confirmed replacement.
In real life: This fork is worth monitoring.
What to look at: What to look at: the CMS Bridge page for updates.
Is BALANCE relevant to you?
Why it matters: The Part D piece of BALANCE is delayed; the Medicaid piece is proceeding.
In real life: This fork depends on which program covers you.
What to look at: What to look at: the BALANCE Model status.
Common questions
Quick answers
Short, plain answers for the questions people usually have next. The source trail stays available below.
When does the Medicare GLP-1 Bridge end?+
CMS says the Bridge was extended through December 31, 2027.
What replaces the Bridge?+
CMS points to potential implementation of the BALANCE Model in Part D, but KFF reports that the Part D piece is indefinitely delayed, so a replacement is not confirmed.
Will my weight-management coverage continue after 2027?+
That is not confirmed. CMS has not set a guaranteed weight-management coverage path for Medicare beneficiaries after the Bridge ends.
Does my diabetes coverage end with the Bridge?+
No. Part D coverage for medical indications such as type 2 diabetes, cardiovascular risk reduction, and sleep apnea continues regardless of the Bridge.
How will I know if this changes?+
Watch the CMS GLP-1 Bridge page and your plan notices, since the post-2027 path is still developing.
How this page is curated
This page uses the CMS GLP-1 Bridge page, KFF for the BALANCE delay, and the Congressional Research Service for the continuing medical-indication coverage. It marks the post-2027 weight-management path as not confirmed rather than implying continuity.
Read the planner methodologyTrust anchor
Sources used on this page
Every source named above is listed here in one place.
CMS. Medicare GLP-1 Bridge
https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridgeCongressional Research Service. Medicare Coverage of GLP-1 Drugs
https://www.congress.gov/crs-product/IF12758KFF. GLP-1s in Medicare and Medicaid
https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
Before you act on this
This plan is educational. It is not personalized financial, tax, or insurance advice. Projections illustrate the math, they do not predict the future. Talk to your own licensed financial professional before acting on any of it.